Jump to content
Sclero Forums

Search the Community

Showing results for tags 'vasculitis'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Worldwide
    • Welcome: Guidelines and FAQs
    • Sclero Forums (MAIN)
    • UK Scleroderma
    • News
    • Personal Support

Blogs

  • CFM Babs from Chorley FM
  • barefut impressions
  • My Two Cents...
  • Amanda Thorpe's Blog
  • Joelf's Blog
  • Michael Thorpe's Blog

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


Location

Found 20 results

  1. The Longitudinal Course of Fatigue in Antineutrophil Cytoplasmic Antibody-associated Vasculitis (AAV). This study longitudinally measured fatigue levels in patients with AAV. PubMed, J Rheumatol, 2020 Apr;47(4):572-579. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  2. Outcome Measures in Large-Vessel Vasculitis: Relationship Between Patient, Physician, Imaging, and Laboratory-Based Assessments. Measures of disease assessment in large-vessel vasculitis consist of independent outcomes, supporting the need to develop a standard set of measures covering multiple types of outcomes. PubMed, Arthritis Care Res (Hoboken), 11/30/2019. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  3. Risk factors associated with IgA vasculitis with nephritis (VN) (Henoch-Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis. This meta-analysis showed that older age at onset, lower GFR, initial renal features and renal biopsy with crescentic nephritis were predictive of poor prognosis in children with IgA-VN. PubMed, PLoS One, 2019 Oct 1;14(10):e0223218. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  4. Serum neopterin and ischemia modified albumin (IMA) levels are associated with the disease activity of adult immunoglobulin A vasculitis (Henoch-Schönlein purpura). Roles of high-sensitivity C-reactive protein, neopterin and IMA as potential markers of diagnosis and disease activity seem to be worth studying in future studies with larger study groups. PubMed, Int J rheumatologist Dis, 08/14/2019. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  5. Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis (AAV): Is There Still a Role for Cyclophosphamide (CYC)? With the emergence of newer agents with more favorable safety profiles, CYC is no longer the cornerstone of management of AAV. PubMed, Rheum Dis Clin North Am, 2019 Aug;45(3):379-398. (Also see Vasculitis and Immunosuppressants) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  6. Association between histopathologic changes and expression of selected microRNAs in skin of adult patients with IgA vasculitis. Further investigation of miRNAs expression in the affected tissues could improve knowledge of IgAV pathogenesis and possibly help to identify novel biomarkers in body fluids. PubMed, Histopathology, 05/28/2019. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  7. Prognostic Value of Microscopic Hematuria after Induction of Remission in Antineutrophil Cytoplasmic Antibodies–Associated Vasculitis. Hematuria at remission after a first pauci–immune glomerulonephritis flare was not associated with end–stage renal disease but with the occurrence of renal relapse within 44 months of remission. PubMed, Am J Nephrol, 2019 May 22;49(6):479-486. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  8. Prognostic nutritional index is associated with disease severity and relapse in ANCA–associated vasculitis. Prognostic nutritional index at diagnosis might be useful for assessing disease severity and predicting the prognosis of AAV patients. PubMed, Int J rheumatologist Dis, 02/06/2019. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  9. Early predictors of one–year mortality in patients over 65 presenting with ANCA–associated renal vasculitis: a retrospective, multicentre study. A reduction in immunosuppression, the early detection of infections, and co–trimoxazole prophylaxis might help to reduce mortality in this population. PubMed, BMC Nephrol, 2018 Nov 9;19(1):317. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  10. Smoking Is a Risk Factor for Relapse of Antimyeloperoxidase Antibodies–Associated Vasculitis. Smoking is a significant and dose–dependent risk factor for relapse of microscopic polyangiitis (MPA) and patients with MPA who smoke should be encouraged to quit. PubMed, J Clin Rheumatol, 2018 Oct;24(7):361-367. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  11. Mortality and causes of death across the systemic connective tissue diseases (CTDs) and the primary systemic vasculitides (PSVs). We observed premature deaths across the spectrum of CTDs and PSVs, with highest standard mortality ratios in diffuse scleroderma and anti–synthetase syndrome. PubMed, Rheumatology (Oxford), 10/03/2018. (Also see Connective Tissue Disease and Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  12. MicroRNA expression in the affected skin of adult patients with IgA vasculitis. A positive association between the severity of purpura and skin miRNA-223-3p expression was found and aberrantly expressed miRNAs could represent a biomarker in adult IgAV. PubMed, Clin Rheumatol, 08/06/2018. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  13. Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis (AAV) with systemic autoimmune diseases: an unrecognized example of poliautoimmunity. The most common AAV phenotype was renal–limited vasculitis, and the most frequent overlap disease was rheumatoid arthritis. PubMed, Clin Rheumatol, 07/14/2018. (Also see Vasculitis and Rheumatoid Arthritis in Overlap) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  14. Long–term follow–up of a combined rituximab and cyclophosphamide regimen in renal anti–neutrophil cytoplasm antibody–associated vasculitis (AAV). This regimen is potentially superior to current standards of care, and controlled studies are warranted to establish the utility of combination drug approaches in the treatment of AAV. Nephrology Dialysis Transplantation, 02/14/2018. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  15. Emphysematous change with scleroderma–associated interstitial lung disease (SSc–ILD): the potential contribution of vasculopathy? Peripheral vasculopathy may help to destroy the fibrously thickened alveolar walls, resulting in emphysematous change in SSc–ILD. PubMed, BMC Pulm Med, 2018 Jan 30;18(1):25. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  16. Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody–associated vasculitis (AAV). Promising biomarkers of disease activity, disease severity, and organ involvement in AAV with a targeted proteomics approach using serum samples have been obtained. PubMed, Arthritis Res Ther, 2017 Sep 29;19(1):218. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  17. The Birmingham Vasculitis Activity Score (BVAS) is an independent predictor of cardiovascular events and cardiovascular disease–related mortality in patients with ANCA–associated vasculitis (AAV). Besides the traditional risk factors, BVAS at presentation was an independent predictor of cardiovascular events and cardiovascular diseases–related mortality in patients with AAV. Seminars in Arthritis and Rheumatism, 09/07/2017. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  18. I was just recently diagnosed with Vasculitis. Does anyone else have this?
  19. Randomised controlled trial of prolonged treatment in the remission phase of ANCA–associated vasculitis (AAV). Prolonged remission maintenance therapy with azathioprine/prednisolone, beyond 24 months after diagnosis, reduces relapse risk out to 48 months and improves renal survival in AAV. PubMed, Ann rheumatologist Dis, 05/25/2017. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  20. Paediatric anti–neutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV): an update on renal management. The aim of this article is to provide a comprehensive review of paediatric AAV, with a focus on renal manifestations, and to highlight the recent advances made in therapeutic management. PubMed, Pediatr Nephrol, 01/07/2017. (Also see Vasculitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
×
×
  • Create New...